Post-partum Care in the NICU (PeliCaN)

July 12, 2024 updated by: Heather Burris, University of Pennsylvania
This is a pilot randomized control trial to demonstrate the feasibility of a novel model of dyad-centered, doula-coordinated, midwife-delivered postpartum care located in the NICU in a large urban hospital.

Study Overview

Status

Completed

Conditions

Study Type

Interventional

Enrollment (Actual)

37

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Pennsylvania
      • Philadelphia, Pennsylvania, United States, 19104
        • Hospital of the University of Pennsylvania

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Preterm birth <34 weeks
  • Signed medical record release form

Exclusion Criteria:

  • Unable to read or sign informed consent
  • If the medical team believes that the infant may die or be transferred to another hospital in upcoming weeks
  • PI Discretion

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Doula Coordinated-Care Arm
Postpartum care will be doula-coordinated. The doula will meet with the mother at least once a week during their infant's NICU stay, with a minimum of 3 meetings. Participants will be given the option of seeing the study nurse midwife or their own provider. If the participant opts to see the nurse midwife, they can meet in a private office located in the NICU. The doula, as typical of the doula role, will coordinate any needed community services in the transition to home.
A doula will coordinate all postpartum care and provide support to the participant. A midwife will be available on-site in the NICU to provide postpartum care.
No Intervention: Standard Postpartum Care Arm
In this arm participants will receive usual postpartum care. They will be discharged from the hospital while their baby is still in the NICU and a plan will be made to for follow-up with their provider as an outpatient at some point in the next 6 weeks. The study coordinator will provide the participant with a community postpartum resources list.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Time to receipt of postpartum care
Time Frame: birth until 6 weeks post-partum
To be analyzed using a wilcoxin rank sum test
birth until 6 weeks post-partum

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Comparison of effectiveness of intervention for mothers with public vs private insurance
Time Frame: birth until 6 weeks post-partum
Time to receipt of postpartum care will be compared between mothers with public vs private insurance
birth until 6 weeks post-partum
Comparison of effectiveness of intervention for mothers with infants less than 29 weeks gestational age vs those 29 weeks or older.
Time Frame: birth until 6 weeks post-partum
Time to receipt of postpartum care will be compared between mothers with infants with a gestational age of less than or equal to 28 6/7 weeks vs a gestational age greater than or equal to 29 weeks
birth until 6 weeks post-partum
Receipt of Postpartum care
Time Frame: birth until 6 weeks post-partum
Binary (yes/no), fishers exact test
birth until 6 weeks post-partum

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Health related quality of life measured by the CDC Health-Related Quality of Life (HRQOL)
Time Frame: 6 months postpartum
A 14 item survey scoring between 0 and 30, in which a higher score represents a worse health related quality of life
6 months postpartum
Depression measured by the Edinburgh Postnatal Depression Scale
Time Frame: 6 months postpartum
Scored 0 through 30, with 30 indicating a worse outcome
6 months postpartum
Health care utilization - Number of visits
Time Frame: Time of birth until 6 months postpartum
PhenXToolkit- 270101 Heathcare utilization and access survery
Time of birth until 6 months postpartum
Breastfeeding- ever
Time Frame: 6 months postpartum
PhenXToolkit-50101 BreasfeedingOutcomes: ever received breastmilk
6 months postpartum
Breastfeeding- length of time exclusive breastmilk
Time Frame: 6 months postpartum
PhenXToolkit-50101 BreasfeedingOutcomes: length of time exclusive breastmilk
6 months postpartum
Breastfeeding- age at stopping breastmilk
Time Frame: 6 months postpartum
PhenXToolkit-50101 BreasfeedingOutcomes:age at stopping breastmilk receipt (if relevant))
6 months postpartum
Diet
Time Frame: 6 months postpartum
Dietary Screener Questionaire (DSQ) 30-items NHANES (Outcome: Cups of fruits or vegetables per day, [more is better])
6 months postpartum
Physical activity
Time Frame: 6 months postpartum
International physical activity questionnaire - short form (Scored as Total physical activity, expressed as minutes per week)
6 months postpartum
Posttraumatic stress disorder symptoms (PTSD)
Time Frame: 6 months postpartum
PTSD Checklist for DSM-5 (PCL-5), Scored 0 to 40 with a 40 indicating a worse outcome.
6 months postpartum

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 29, 2022

Primary Completion (Actual)

May 14, 2024

Study Completion (Actual)

May 14, 2024

Study Registration Dates

First Submitted

August 17, 2022

First Submitted That Met QC Criteria

August 18, 2022

First Posted (Actual)

August 22, 2022

Study Record Updates

Last Update Posted (Actual)

July 15, 2024

Last Update Submitted That Met QC Criteria

July 12, 2024

Last Verified

July 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • 851606

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Postpartum Period

Subscribe